A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease

<div>Compound-target-pathway network. Green circles represent bioactive components from LLF, yellow circles represent bioactive components from EH, red circles represent duplicated components of EH and LLF, blue hexagons represent putative targets, and orange V shapes represent the top 20 pathways.</div>

Journal of Diabetes Research

fig5

Figure 5

Figure 5: A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease 

Figure 5 | A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease 